Revolutionizing the battle against locally advanced breast cancer: A comprehensive insight into neoadjuvant radiotherapy.
Xiangyi KongJiarui SongPeng GaoRan GaoLin ZhangYi FangYipeng WangJidong GaoJing WangPublished in: Medicinal research reviews (2023)
Breast cancer (BC) constitutes one of the most pervasive malignancies affecting the female population. Despite progressive improvements in diagnostic and therapeutic technologies, leading to an increased detection of early stage BCs, locally advanced breast cancer (LABC) persists as a significant clinical challenge. Owing to its poor overall survival (OS) rate, elevated recurrence rate, and high potential for distant metastasis, LABC prominently impacts the comprehensive efficacy of BC treatments. Radiotherapy, encompassing preoperative, intraoperative, and postoperative modalities, is acknowledged as an effective strategy for mitigating BC metastasis and enhancing survival rates among patients. Nevertheless, the domain of preoperative neoadjuvant radiotherapy (NART) remains conspicuously underexplored in clinical studies. Available research suggests that NART can induce tumor volume reduction, provoke fibrotic changes in tumor and adjacent normal tissues, thereby mitigating intraoperative cancer propagation and enhancing the quality of life for LABC patients. This manuscript seeks to provide a review of contemporary research pertaining to LABC and its preoperative radiotherapy.
Keyphrases
- locally advanced
- rectal cancer
- patients undergoing
- neoadjuvant chemotherapy
- squamous cell carcinoma
- early stage
- radiation therapy
- phase ii study
- end stage renal disease
- free survival
- ejection fraction
- lymph node
- newly diagnosed
- gene expression
- chronic kidney disease
- prognostic factors
- systemic sclerosis
- sentinel lymph node
- papillary thyroid
- childhood cancer
- radiation induced
- young adults
- patient reported outcomes
- squamous cell
- label free
- human health
- double blind
- pulmonary fibrosis